| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$43 |
Appendix 4D & Interim Financial Report
|
27 Feb 2026 6:16PM |
$0.115 |
$0.140 |
risen by
21.74%
|
|
CPV - Price-sensitive ASX Announcement
Full Release
Key Points
- ClearVue Technologies Limited reported a total comprehensive loss of $5,246,848 for the period ending 31 December 2025.
- Revenue from contracts with customers amounted to $108,483 in 2025.
- The company has been focusing on developing sales pipelines, licensing activities, and research and development for its solar glass and BIPV technology.
- ClearVue launched its Investor Hub to enhance shareholder engagement.
- The company is advancing its Gen3 technology, achieving significant improvements in energy output and production efficiency.
- ClearVue is collaborating with international partners to expand its market presence in BIPV technology.
- As of 31 December 2025, ClearVue held cash and cash equivalents of $2,047,160.
- There were no dividends declared or recommended for the half-year ending 31 December 2025.
- The directors have confidence in the company’s ability to continue as a going concern.
- No contingent assets or liabilities were reported for the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$4 |
Application for quotation of securities - RGT
|
27 Feb 2026 6:15PM |
$0.056 |
$0.038 |
fallen by
32.14%
|
|
| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$4 |
Half Yearly Report and Accounts
|
27 Feb 2026 6:15PM |
$0.056 |
$0.038 |
fallen by
32.14%
|
|
RGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Argent BioPharma Ltd incurred a net loss of A$2.9 million for the half-year ended 31 December 2025.
- No dividends were declared or paid during this financial period.
- Argent signed a binding agreement to acquire AusCann assets to enhance strategic drug development.
- Successful completion of an independent U.S. study demonstrated ArtemiCâ„¢ efficacy in viral models.
- Argent secured financing agreements providing up to A$11 million for strategic initiatives.
- The company experienced significant cash flows from financing activities, enhancing liquidity.
- A loss was recognized due to the liquidation of its Slovenian subsidiary, Argent BioPharma d.o.o.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$21 |
Application for quotation of securities - 1AI
|
27 Feb 2026 6:13PM |
$0.017 |
$0.011 |
fallen by
38.24%
|
|
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$681 |
Application for quotation of securities - FRS
|
27 Feb 2026 6:13PM |
$0.690 |
$0.510 |
fallen by
26.09%
|
|
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$19 |
Change in substantial holding
|
27 Feb 2026 6:12PM |
$0.018 |
$0.005 |
fallen by
72.22%
|
|
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$19 |
Cleansing Notice
|
27 Feb 2026 6:09PM |
$0.018 |
$0.005 |
fallen by
72.22%
|
|
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$19 |
Application for quotation of securities - CLA
|
27 Feb 2026 6:08PM |
$0.018 |
$0.005 |
fallen by
72.22%
|
|
| GCM Corporation Limited (GCM) ORDINARY FULLY PAID |
Materials |
$23 |
Notice Under Section 708A
|
27 Feb 2026 6:07PM |
$0.017 |
$0.008 |
fallen by
52.94%
|
|
| Michael Hill International Limited (MHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$123 |
FY26H1 Results Presentation
|
27 Feb 2026 6:06PM |
$0.440 |
$0.320 |
fallen by
27.27%
|
|
MHJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Michael Hill International Limited reported a 28.6% increase in comparable EBIT to $31.0 million for FY26H1.
- Revenue growth was recorded across all markets with Canada achieving record sales.
- Same store sales increased by 6.1% in Canada, 4.8% in Australia, and 1.8% in New Zealand.
- The gross margin remained broadly flat at 61.2% despite higher input costs, particularly for gold and silver.
- Inventory levels were reduced by $11.3 million.
- Net cash position improved by $30.5 million, leading to a net cash of $20.7 million.
- The store network was reduced by a net total of nine stores during calendar year 2025.
- No interim dividend was declared, with dividends expected to resume at the full year results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SDI Limited (SDI) ORDINARY FULLY PAID |
Health Care |
$165 |
Appendix 4D Dcember 2025
|
27 Feb 2026 6:05PM |
$0.885 |
$1.390 |
risen by
57.06%
|
|
SDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit after tax decreased by 15.2% to AUD 3.245 million.
- Revenue increased to AUD 52.928 million.
- Profit before tax decreased by 20.6% to AUD 4.307 million.
- EBITDA decreased by 9.4% to AUD 7.823 million.
- Significant growth in aesthetic product sales.
- Amalgam sales declined due to EU regulations.
- Potential acquisition discussions with a global dental materials producer.
- Dividend payments remained consistent.
- Cash and cash equivalents decreased to AUD 4.559 million.
- The company made significant investments in property and equipment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GCM Corporation Limited (GCM) ORDINARY FULLY PAID |
Materials |
$23 |
Application for quotation of securities - GCM
|
27 Feb 2026 6:05PM |
$0.017 |
$0.008 |
fallen by
52.94%
|
|
| Klevo Rewards Limited (KLV) ORDINARY FULLY PAID |
Industrials |
$150 |
Half Yearly Report and Accounts
|
27 Feb 2026 6:04PM |
$0.022 |
$0.097 |
risen by
340.91%
|
|
KLV - Price-sensitive ASX Announcement
Full Release
Key Points
- Klevo Rewards Limited reported a net loss of $815,803 for the half-year.
- Revenues increased to $4,502,767, mainly from item sales and fees.
- Increased costs in sales and professional fees contributed to the loss.
- Substantial equity contributions were made, raising additional capital.
- Cash and cash equivalents increased significantly to $3,875,235.
- The company ended the period with net liabilities of $3,444.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bellevue Gold Limited (BGL) ORDINARY FULLY PAID |
Materials |
$2,296 |
Notification regarding unquoted securities - BGL
|
27 Feb 2026 6:04PM |
$1.825 |
$1.540 |
fallen by
15.62%
|
|
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$1,444 |
Change of Director's Interest Notice - Stoneburner
|
27 Feb 2026 6:04PM |
$0.215 |
$0.255 |
risen by
18.60%
|
|
| Schroder Real Return Fund (Managed Fund) (GROW) |
Financials |
$79 |
GROW Distribution - Feb 2026
|
27 Feb 2026 6:03PM |
$4.090 |
$4.070 |
fallen by
0.49%
|
|
| Glennon Small Companies Limited (GC1) ORDINARY FULLY PAID |
Financials |
$19 |
NTA Estimate - 26 February 2026
|
27 Feb 2026 6:03PM |
$0.445 |
$0.390 |
fallen by
12.36%
|
|
| Michael Hill International Limited (MHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$123 |
FY26H1 Results
|
27 Feb 2026 6:03PM |
$0.440 |
$0.320 |
fallen by
27.27%
|
|
MHJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Comparable EBIT increased by 28.6% to $31.0m.
- Group sales rose by 3.0% to $371.0m.
- Same store sales grew by 3.8%.
- Strong performance in Canada with 6.1% same store sales growth.
- Gross margin stable at 61.2%.
- Net cash position improved by $30.5m.
- No interim dividend declared; focus on sustainable dividends.
- Product innovation and new flagship stores opened.
- Upcoming Investor Day to discuss strategy and performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resolution Minerals Ltd (RML) ORDINARY FULLY PAID |
Materials |
$99 |
Cleansing Notice - Share Issue
|
27 Feb 2026 6:02PM |
$0.040 |
$0.044 |
risen by
10%
|
|
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$139 |
Appendix 4D and Interim Financial Report
|
27 Feb 2026 6:02PM |
$0.540 |
$0.480 |
fallen by
11.11%
|
|
RCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported a half-year operating loss of $16,559,726 for 2025.
- Increased R&D expenses and share-based payments contributed to the loss.
- Active progression of RECCE® 327 in clinical trials.
- Received an A$85 million grant for synthetic antibiotic R&D.
- Secured a cash receipt of A$5,339,203 from the R&D tax incentive rebate.
- No dividends declared during the period.
- Uncertainty about continuing as a going concern without additional funding.
- Plans to raise additional funds through debt or equity.
- Significant investment in R&D for antibiotic-resistant and viral pathogen treatments.
- Expansion in clinical trial sites in Indonesia for diabetic foot infections.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeris Environmental Ltd (AEI) ORDINARY FULLY PAID |
Industrials |
$9 |
Change in substantial holding - BS
|
27 Feb 2026 6:01PM |
$0.043 |
$0.038 |
fallen by
11.63%
|
|
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$1,444 |
Notification regarding unquoted securities - TBN
|
27 Feb 2026 6:01PM |
$0.215 |
$0.255 |
risen by
18.60%
|
|
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$681 |
Application for quotation of securities - FRS
|
27 Feb 2026 6:01PM |
$0.690 |
$0.510 |
fallen by
26.09%
|
|
| Javelin Minerals Limited (JAV) ORDINARY FULLY PAID |
Materials |
$22 |
Application for quotation of securities - JAV
|
27 Feb 2026 6:01PM |
$0.145 |
$0.080 |
fallen by
44.83%
|
|
| Resolution Minerals Ltd (RML) ORDINARY FULLY PAID |
Materials |
$99 |
Notification regarding unquoted securities - RML
|
27 Feb 2026 5:58PM |
$0.040 |
$0.044 |
risen by
10%
|
|